AAPL293.83+4.47 (+1.54%) ▲|ABBV250.91-0.74 (-0.29%) ▼|ABT92.23+1.49 (+1.64%) ▲|ACN131.48+7.04 (+5.66%) ▲|ADBE211.32+6.30 (+3.07%) ▲|AMAT653.06-69.95 (-9.67%) ▼|AMD544.39-36.52 (-6.29%) ▼|AMGN361.22-0.91 (-0.25%) ▼|AMT165.42+1.85 (+1.13%) ▲|AMZN241.80+3.46 (+1.45%) ▲|AVGO371.43-6.33 (-1.67%) ▼|AXP348.39+10.14 (+3.00%) ▲|BA218.90+2.43 (+1.12%) ▲|BAC58.38+1.40 (+2.46%) ▲|BKNG182.65+4.41 (+2.48%) ▲|BLK985.83+24.27 (+2.52%) ▲|BMY56.58-1.04 (-1.81%) ▼|BNY146.43+1.82 (+1.26%) ▲|BRK-B501.32+0.93 (+0.19%) ▲|C140.53+0.57 (+0.41%) ▲|CAT995.21-69.69 (-6.54%) ▼|CL92.40+0.72 (+0.78%) ▲|CMCSA23.74-0.82 (-3.32%) ▼|COF204.58+3.96 (+1.97%) ▲|COP103.35-0.61 (-0.58%) ▼|COST923.50-11.97 (-1.28%) ▼|CRM163.73+7.07 (+4.51%) ▲|CSCO116.84-0.62 (-0.53%) ▼|CVS104.72+1.27 (+1.23%) ▲|CVX165.50-0.26 (-0.16%) ▼|DE630.74-3.59 (-0.57%) ▼|DHR193.93+3.45 (+1.81%) ▲|DIS95.92-0.33 (-0.34%) ▼|DUK125.75-0.83 (-0.66%) ▼|EMR140.02-3.14 (-2.19%) ▼|FDX313.91+0.78 (+0.25%) ▲|GD363.33+9.09 (+2.57%) ▲|GE374.49+0.76 (+0.20%) ▲|GEV1,132.37-42.49 (-3.62%) ▼|GILD126.22-0.12 (-0.10%) ▼|GM75.58-1.50 (-1.95%) ▼|GOOG357.81+4.48 (+1.27%) ▲|GOOGL361.01+3.64 (+1.02%) ▲|GS1,021.36+9.99 (+0.99%) ▲|HD351.43-1.26 (-0.36%) ▼|HON221.77-2.13 (-0.95%) ▼|IBM287.23+6.02 (+2.14%) ▲|INTC127.45-12.18 (-8.72%) ▼|INTU268.67+7.67 (+2.94%) ▲|ISRG400.93+3.25 (+0.82%) ▲|JNJ253.86-0.11 (-0.04%) ▼|JPM333.59+6.26 (+1.91%) ▲|KO81.18-0.09 (-0.11%) ▼|LIN533.18+14.24 (+2.74%) ▲|LLY1,193.00-6.43 (-0.54%) ▼|LMT521.83+12.37 (+2.43%) ▲|LOW221.90+1.41 (+0.64%) ▲|LRCX390.26-43.08 (-9.94%) ▼|MA523.26+9.66 (+1.88%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.89+1.05 (+1.82%) ▲|MDT79.26+1.03 (+1.32%) ▲|META612.70+49.41 (+8.77%) ▲|MMM160.51-1.40 (-0.86%) ▼|MO71.38-0.58 (-0.80%) ▼|MRK125.68-2.83 (-2.20%) ▼|MS211.86+2.82 (+1.35%) ▲|MSFT383.80+10.78 (+2.89%) ▲|MU1,047.70-106.59 (-9.23%) ▼|NEE86.66-1.11 (-1.26%) ▼|NFLX74.04+2.64 (+3.69%) ▲|NKE42.93+1.88 (+4.57%) ▲|NOW106.08+6.80 (+6.84%) ▲|NVDA197.97-2.12 (-1.06%) ▼|ORCL143.09-3.46 (-2.36%) ▼|PEP140.51+5.11 (+3.77%) ▲|PFE23.88-0.20 (-0.83%) ▼|PG147.05+0.41 (+0.28%) ▲|PLTR126.08+9.41 (+8.07%) ▲|PM177.08-3.83 (-2.12%) ▼|QCOM183.54-1.25 (-0.68%) ▼|RTX191.21+1.48 (+0.78%) ▲|SBUX102.63+0.44 (+0.43%) ▲|SCHW95.91+3.64 (+3.94%) ▲|SO95.32-0.39 (-0.41%) ▼|SPG222.55-1.11 (-0.49%) ▼|T20.40-0.30 (-1.45%) ▼|TMO514.50+13.14 (+2.62%) ▲|TMUS172.78+5.05 (+3.01%) ▲|TSLA425.70+5.10 (+1.21%) ▲|TXN299.34+1.27 (+0.43%) ▲|UBER72.78+0.62 (+0.85%) ▲|UNH427.38+11.75 (+2.83%) ▲|UNP277.01+5.01 (+1.84%) ▲|UPS109.74+2.24 (+2.08%) ▲|USB62.01+1.61 (+2.66%) ▲|V350.40+7.31 (+2.13%) ▲|VZ41.76-0.58 (-1.37%) ▼|WFC85.69+3.05 (+3.68%) ▲|WMT108.83-4.44 (-3.92%) ▼|XOM135.78-0.94 (-0.69%) ▼|AAPL293.83+4.47 (+1.54%) ▲|ABBV250.91-0.74 (-0.29%) ▼|ABT92.23+1.49 (+1.64%) ▲|ACN131.48+7.04 (+5.66%) ▲|ADBE211.32+6.30 (+3.07%) ▲|AMAT653.06-69.95 (-9.67%) ▼|AMD544.39-36.52 (-6.29%) ▼|AMGN361.22-0.91 (-0.25%) ▼|AMT165.42+1.85 (+1.13%) ▲|AMZN241.80+3.46 (+1.45%) ▲|AVGO371.43-6.33 (-1.67%) ▼|AXP348.39+10.14 (+3.00%) ▲|BA218.90+2.43 (+1.12%) ▲|BAC58.38+1.40 (+2.46%) ▲|BKNG182.65+4.41 (+2.48%) ▲|BLK985.83+24.27 (+2.52%) ▲|BMY56.58-1.04 (-1.81%) ▼|BNY146.43+1.82 (+1.26%) ▲|BRK-B501.32+0.93 (+0.19%) ▲|C140.53+0.57 (+0.41%) ▲|CAT995.21-69.69 (-6.54%) ▼|CL92.40+0.72 (+0.78%) ▲|CMCSA23.74-0.82 (-3.32%) ▼|COF204.58+3.96 (+1.97%) ▲|COP103.35-0.61 (-0.58%) ▼|COST923.50-11.97 (-1.28%) ▼|CRM163.73+7.07 (+4.51%) ▲|CSCO116.84-0.62 (-0.53%) ▼|CVS104.72+1.27 (+1.23%) ▲|CVX165.50-0.26 (-0.16%) ▼|DE630.74-3.59 (-0.57%) ▼|DHR193.93+3.45 (+1.81%) ▲|DIS95.92-0.33 (-0.34%) ▼|DUK125.75-0.83 (-0.66%) ▼|EMR140.02-3.14 (-2.19%) ▼|FDX313.91+0.78 (+0.25%) ▲|GD363.33+9.09 (+2.57%) ▲|GE374.49+0.76 (+0.20%) ▲|GEV1,132.37-42.49 (-3.62%) ▼|GILD126.22-0.12 (-0.10%) ▼|GM75.58-1.50 (-1.95%) ▼|GOOG357.81+4.48 (+1.27%) ▲|GOOGL361.01+3.64 (+1.02%) ▲|GS1,021.36+9.99 (+0.99%) ▲|HD351.43-1.26 (-0.36%) ▼|HON221.77-2.13 (-0.95%) ▼|IBM287.23+6.02 (+2.14%) ▲|INTC127.45-12.18 (-8.72%) ▼|INTU268.67+7.67 (+2.94%) ▲|ISRG400.93+3.25 (+0.82%) ▲|JNJ253.86-0.11 (-0.04%) ▼|JPM333.59+6.26 (+1.91%) ▲|KO81.18-0.09 (-0.11%) ▼|LIN533.18+14.24 (+2.74%) ▲|LLY1,193.00-6.43 (-0.54%) ▼|LMT521.83+12.37 (+2.43%) ▲|LOW221.90+1.41 (+0.64%) ▲|LRCX390.26-43.08 (-9.94%) ▼|MA523.26+9.66 (+1.88%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.89+1.05 (+1.82%) ▲|MDT79.26+1.03 (+1.32%) ▲|META612.70+49.41 (+8.77%) ▲|MMM160.51-1.40 (-0.86%) ▼|MO71.38-0.58 (-0.80%) ▼|MRK125.68-2.83 (-2.20%) ▼|MS211.86+2.82 (+1.35%) ▲|MSFT383.80+10.78 (+2.89%) ▲|MU1,047.70-106.59 (-9.23%) ▼|NEE86.66-1.11 (-1.26%) ▼|NFLX74.04+2.64 (+3.69%) ▲|NKE42.93+1.88 (+4.57%) ▲|NOW106.08+6.80 (+6.84%) ▲|NVDA197.97-2.12 (-1.06%) ▼|ORCL143.09-3.46 (-2.36%) ▼|PEP140.51+5.11 (+3.77%) ▲|PFE23.88-0.20 (-0.83%) ▼|PG147.05+0.41 (+0.28%) ▲|PLTR126.08+9.41 (+8.07%) ▲|PM177.08-3.83 (-2.12%) ▼|QCOM183.54-1.25 (-0.68%) ▼|RTX191.21+1.48 (+0.78%) ▲|SBUX102.63+0.44 (+0.43%) ▲|SCHW95.91+3.64 (+3.94%) ▲|SO95.32-0.39 (-0.41%) ▼|SPG222.55-1.11 (-0.49%) ▼|T20.40-0.30 (-1.45%) ▼|TMO514.50+13.14 (+2.62%) ▲|TMUS172.78+5.05 (+3.01%) ▲|TSLA425.70+5.10 (+1.21%) ▲|TXN299.34+1.27 (+0.43%) ▲|UBER72.78+0.62 (+0.85%) ▲|UNH427.38+11.75 (+2.83%) ▲|UNP277.01+5.01 (+1.84%) ▲|UPS109.74+2.24 (+2.08%) ▲|USB62.01+1.61 (+2.66%) ▲|V350.40+7.31 (+2.13%) ▲|VZ41.76-0.58 (-1.37%) ▼|WFC85.69+3.05 (+3.68%) ▲|WMT108.83-4.44 (-3.92%) ▼|XOM135.78-0.94 (-0.69%) ▼|
33.8 C
New York
Wednesday, July 1, 2026

Tag: patients

newssourceFORcompanyinformationcontent1releasesmarket

Intrinsic Therapeutics, Inc. Announces That ISASS Has Issued Updated 2025 Recommendations and Coverage Criteria for Barricaid Bone-Anchored Annular Closure

BOSTON, June 19, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company committed to redefining the standard of care for lumbar discectomy patients with...

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J., June 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 16, 2025, the company approved non-statutory stock options...

New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes

LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical...

CD5 Targeted Therapies CD5 Targeting CAR T Cell Therapy Clinical Trials Market Insight 2025

First CD5 Targeted Therapy Commercial Launch Expected By 2030 Says Kuick Research 
First CD5 Targeted Therapy Commercial Launch Expected By 2030 Says Kuick Research

RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma

Research Published in NEJM Evidence and presented at the International Conference on Malignant Lymphoma NEW BRUNSWICK, N.J. and BOSTON, June 19, 2025 /PRNewswire/ -- Researchers from...

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells

If approved, Zemcelpro® is expected to:increase access to donor-derived stem cell transplantation, which offers a potentially curative option for haematologic malignancies, including leukemias and myelodysplastic syndromesbe...

Happy Ring Earns Second FDA Clearance–Now Approved for At-Home Sleep Testing to Simplify the Diagnosis and Treatment of Sleep Apnea and Related Health Conditions

First FDA-cleared smart ring for multi-night sleep testing and 24/7 biometrics — to catch disease early—years before standard care. AUSTIN, Texas, June 19, 2025 /PRNewswire/...

Japan’s Top Eczema App, Atopiyo, Launches in the US: Pioneering Digital Eczema Care

11-time award winner, university-backed, delivers what 31M patients need most — visual tracking, peer support, AI analysis CHIBA, Japan, June 19, 2025 /PRNewswire/ -- Living...

Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment

Theranica is presenting three real-world evidence studies at the American Headache Society (AHS) 67th Annual Scientific Congress.

RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome

Lilly Collaboration Accelerates RyboDyn's Dark Proteome Targets Toward First-in-Class Therapies SAN DIEGO, June 19, 2025 /PRNewswire/ -- RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies...

Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late...

PRESS RELEASE

Pharmacy Times® Releases 2025 OTC Guide® Featuring Brands Most Recommended by Pharmacists Nationwide

Trusted consumer resource now in its 29th year highlights the top over the counter (OTC) products across 149 categories 
Trusted consumer resource now in its 29th year highlights the top over the counter (OTC) products across 149 categories

Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations

SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the...

Catholic Health Teams Up with Olympic Gold Medalist Katie Ledecky to Help Patients Optimize Their Health

Catholic Health is teaming up with Olympic gold medalist and 21-time world champion swimmer Katie Ledecky to launch a public education campaign.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers